Aspire Biopharma Holdings Inc. (ASBP)
NASDAQ
7.97
+0.15 (+1.92%)
Closed
Aug 21, 2026
Day's Range
7.908.20
52 wk Range
0.110026.00
Financial Statements - ASBP - Aspire Biopharma Holdings Inc.
Revenue
6.20K
Net Income
-24.48M▼ 95.3%Net Margin -394725.1%
EBITDA
-15.49M▼ 33.0%
Free Cash Flow
-4.92M▼ 1756.6%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Sales | 6.20K | 0 | 0 | 0 |
| Cost of Goods | 6.31K | - | 0 | 0 |
| Gross Profit | -116 | - | 0 | 0 |
 Operating Expense | - | - | - | - |
| Operating Income | -19.35M | -3.08M | -1.34M | -596.49K |
| Non-Operating Interest | - | - | - | - |
| Other Income Expense | 3.40M | -9.10M | - | - |
| Pre Tax Income | -24.48M | -12.53M | 4.46M | -596.49K |
| Income Tax | 0 | - | 481 | 626 |
| Net Income | -24.48M | -12.53M | 4.46M | -597.11K |
| EPS Basic | -491.4 | -10.900377 | 0.097029 | -0.012998 |
| EPS Diluted | -491.4 | -10.900377 | 0.097029 | -0.012998 |
| Basic Shares Outstanding | 49.83K | 1.15M | 46M | 45.93M |
| Diluted Shares Outstanding | 49.83K | 1.15M | 46M | 45.93M |
| Ebit | -15.94M | -11.64M | 4.47M | -596.49K |
| Ebitda | -15.49M | -11.64M | 4.47M | -596.49K |
| Net Income Continuous Operations | -24.48M | -1.30M | -359.07K | -597.11K |
| Minority Interests | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
